NO20013971L - Fremgangsmåte ved fremstilling av (2R)-2-propyloktansyre - Google Patents
Fremgangsmåte ved fremstilling av (2R)-2-propyloktansyreInfo
- Publication number
- NO20013971L NO20013971L NO20013971A NO20013971A NO20013971L NO 20013971 L NO20013971 L NO 20013971L NO 20013971 A NO20013971 A NO 20013971A NO 20013971 A NO20013971 A NO 20013971A NO 20013971 L NO20013971 L NO 20013971L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- propyloctanoic acid
- acid
- propyloctanoic
- octanoic acid
- Prior art date
Links
- YCYMCMYLORLIJX-SNVBAGLBSA-N (2r)-2-propyloctanoic acid Chemical compound CCCCCC[C@H](C(O)=O)CCC YCYMCMYLORLIJX-SNVBAGLBSA-N 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 2
- RXAINMDCYOMAHC-SNVBAGLBSA-N (2s)-2-prop-2-enyloctanoic acid Chemical compound CCCCCC[C@H](C(O)=O)CC=C RXAINMDCYOMAHC-SNVBAGLBSA-N 0.000 abstract 1
- DUQSBRQHALCSLC-SNVBAGLBSA-N (2s)-2-prop-2-ynyloctanoic acid Chemical compound CCCCCC[C@H](C(O)=O)CC#C DUQSBRQHALCSLC-SNVBAGLBSA-N 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 238000006317 isomerization reaction Methods 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 229910052697 platinum Inorganic materials 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/42—Platinum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J21/00—Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
- B01J21/18—Carbon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/36—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3975899 | 1999-02-18 | ||
| PCT/JP2000/000900 WO2000048982A1 (en) | 1999-02-18 | 2000-02-17 | Process for the preparation of (2r)-2-propyloctanoic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20013971L true NO20013971L (no) | 2001-08-15 |
| NO20013971D0 NO20013971D0 (no) | 2001-08-15 |
Family
ID=12561862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20013971A NO20013971D0 (no) | 1999-02-18 | 2001-08-15 | Fremgangsmate ved fremstilling av (2R)-2-propyloktansyre |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6608221B1 (de) |
| EP (3) | EP1721882A1 (de) |
| JP (2) | JP4752989B2 (de) |
| KR (1) | KR100666423B1 (de) |
| CN (4) | CN1907938A (de) |
| AT (1) | ATE359256T1 (de) |
| AU (1) | AU776927B2 (de) |
| BR (1) | BR0008261A (de) |
| CA (1) | CA2364308C (de) |
| DE (1) | DE60034316T2 (de) |
| ES (1) | ES2283287T3 (de) |
| HU (1) | HUP0200358A3 (de) |
| MX (1) | MXPA01008241A (de) |
| NO (1) | NO20013971D0 (de) |
| NZ (1) | NZ513569A (de) |
| RU (1) | RU2297406C2 (de) |
| TW (1) | TWI268921B (de) |
| WO (1) | WO2000048982A1 (de) |
| ZA (1) | ZA200106500B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI268921B (en) * | 1999-02-18 | 2006-12-21 | Ono Pharmaceutical Co | A process for preparing (2R)-2-propyloctanoic acid |
| CA2453478A1 (en) | 2001-07-18 | 2003-01-30 | Ono Pharmaceutical Co., Ltd. | Agent for treatment of cerebral ischemic diseases |
| JP2005298334A (ja) * | 2001-12-19 | 2005-10-27 | Ono Pharmaceut Co Ltd | 新規な中間体化合物およびそれを用いる化合物の製造方法 |
| WO2005032536A1 (ja) * | 2003-10-03 | 2005-04-14 | Ono Pharmaceutical Co., Ltd. | (２ｒ)−２−プロピルオクタン酸を有効成分とする薬剤 |
| JP4715516B2 (ja) * | 2003-10-03 | 2011-07-06 | 小野薬品工業株式会社 | （２ｒ）−２−プロピルオクタン酸を有効成分とする輸液製剤 |
| US7928143B2 (en) * | 2003-10-03 | 2011-04-19 | Ono Pharmaceutical Co., Ltd. | Method for preventing and/or treating neurodegenerative diseases |
| EP1741697B1 (de) * | 2004-04-28 | 2012-12-19 | Ono Pharmaceutical Co., Ltd. | Kristall, enthaltend (2r)-2-propyloctansäure und dibenzylamin |
| JP2008520569A (ja) * | 2004-11-16 | 2008-06-19 | メルク エンド カムパニー インコーポレーテッド | 卒中を治療するための（２ｒ）−２−プロピルオクタン酸のプロドラッグ |
| JPWO2006075596A1 (ja) * | 2005-01-13 | 2008-06-12 | 株式会社クラレ | ２−アリルカルボン酸化合物の製造方法 |
| WO2006098292A1 (ja) | 2005-03-15 | 2006-09-21 | Ono Pharmaceutical Co., Ltd. | 眼疾患治療剤 |
| EP2465499A3 (de) | 2005-06-27 | 2013-02-13 | Ono Pharmaceutical Co., Ltd. | Therapeutischer Wirkstoff zur Behandlung von Schmerzen |
| EP1938814A4 (de) | 2005-10-18 | 2009-06-03 | Ono Pharmaceutical Co | Pharmazeutisches mittel zum schutz des motorischen nervs bei patienten mit amyotropher lateralsklerose |
| WO2007072902A1 (ja) | 2005-12-22 | 2007-06-28 | Ono Pharmaceutical Co., Ltd. | 急性期脳梗塞治療剤 |
| WO2007094404A1 (ja) * | 2006-02-16 | 2007-08-23 | Sumitomo Chemical Company, Limited | 光学活性カルボン酸化合物の製造方法 |
| WO2007130419A2 (en) * | 2006-05-04 | 2007-11-15 | Merck & Co., Inc. | Histone deacetylase inhibitors for the treatment of neurodegeneration |
| CN102417445B (zh) * | 2011-11-05 | 2013-11-13 | 中国科学院山西煤炭化学研究所 | 一种由马来酸合成丁二酸的方法 |
| CN102675166B (zh) * | 2012-05-11 | 2014-03-26 | 山东齐都药业有限公司 | 用于制备2-丙基庚酸的新中间体、其制备方法及2-丙基庚酸的制备方法 |
| CN102786407B (zh) * | 2012-08-15 | 2014-04-16 | 湖北大学 | 一种制备(2r)-2-丙基辛酸的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2317019A1 (de) | 1972-04-27 | 1973-11-08 | Upjohn Co | Neue 4,5-didehydro-prostaglandine |
| JPH0672123B2 (ja) | 1986-08-21 | 1994-09-14 | セントラル硝子株式会社 | トリフルオロメチル基を有するシクロヘキサンカルボン酸の製造方法 |
| JP2868183B2 (ja) | 1988-02-29 | 1999-03-10 | 株式式社三和化学研究所 | 光学活性を有する４−オキソ−１−ベンゾピラン−２−カルボン酸誘導体の製法、その合成用中間体並びに該中間体の製法 |
| US5202474A (en) * | 1989-06-22 | 1993-04-13 | Monsanto Company | Asymmetric catalytic hydrogenation of α-arylpropenoic acids |
| EP0632008B1 (de) | 1993-06-01 | 1998-02-04 | Ono Pharmaceutical Co., Ltd. | Pentansäurederivate |
| JP3032447B2 (ja) * | 1995-04-24 | 2000-04-17 | 小野薬品工業株式会社 | 光学活性な２−プロピルオクタン酸の製造方法 |
| JP3084345B2 (ja) * | 1995-04-26 | 2000-09-04 | 小野薬品工業株式会社 | 光学活性な２−プロピルオクタン酸の製造方法 |
| TW509672B (en) | 1998-05-12 | 2002-11-11 | Ono Pharmaceutical Co | Novel intermediate compounds and processes for the production of optical active octanoic acid derivatives |
| TWI268921B (en) * | 1999-02-18 | 2006-12-21 | Ono Pharmaceutical Co | A process for preparing (2R)-2-propyloctanoic acid |
| EP1741697B1 (de) * | 2004-04-28 | 2012-12-19 | Ono Pharmaceutical Co., Ltd. | Kristall, enthaltend (2r)-2-propyloctansäure und dibenzylamin |
-
2000
- 2000-02-16 TW TW089102580A patent/TWI268921B/zh not_active IP Right Cessation
- 2000-02-17 CN CNA2006101002245A patent/CN1907938A/zh active Pending
- 2000-02-17 BR BR0008261-9A patent/BR0008261A/pt not_active Application Discontinuation
- 2000-02-17 CA CA002364308A patent/CA2364308C/en not_active Expired - Fee Related
- 2000-02-17 EP EP06012510A patent/EP1721882A1/de not_active Withdrawn
- 2000-02-17 ES ES00904007T patent/ES2283287T3/es not_active Expired - Lifetime
- 2000-02-17 CN CNB008040133A patent/CN1183082C/zh not_active Expired - Fee Related
- 2000-02-17 WO PCT/JP2000/000900 patent/WO2000048982A1/ja not_active Ceased
- 2000-02-17 CN CNA2006100997275A patent/CN101100422A/zh active Pending
- 2000-02-17 EP EP00904007A patent/EP1153910B1/de not_active Expired - Lifetime
- 2000-02-17 JP JP2000599723A patent/JP4752989B2/ja not_active Expired - Fee Related
- 2000-02-17 HU HU0200358A patent/HUP0200358A3/hu unknown
- 2000-02-17 RU RU2001125501/04A patent/RU2297406C2/ru active
- 2000-02-17 AT AT00904007T patent/ATE359256T1/de not_active IP Right Cessation
- 2000-02-17 EP EP06012511A patent/EP1714956A1/de not_active Withdrawn
- 2000-02-17 NZ NZ513569A patent/NZ513569A/xx not_active IP Right Cessation
- 2000-02-17 DE DE60034316T patent/DE60034316T2/de not_active Expired - Lifetime
- 2000-02-17 CN CNB2004100927127A patent/CN100430364C/zh not_active Expired - Fee Related
- 2000-02-17 US US09/890,651 patent/US6608221B1/en not_active Expired - Fee Related
- 2000-02-17 MX MXPA01008241A patent/MXPA01008241A/es active IP Right Grant
- 2000-02-17 KR KR1020017010357A patent/KR100666423B1/ko not_active Expired - Fee Related
- 2000-02-17 AU AU25730/00A patent/AU776927B2/en not_active Ceased
-
2001
- 2001-08-07 ZA ZA200106500A patent/ZA200106500B/en unknown
- 2001-08-15 NO NO20013971A patent/NO20013971D0/no not_active Application Discontinuation
-
2010
- 2010-05-20 JP JP2010116000A patent/JP5343925B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kimura et al. | Evidence for two different forms of guanylate cyclase in rat heart | |
| Baertschi et al. | Absolute configuration of cis-12-oxophytodienoic acid of flaxseed: implications for the mechanism of biosynthesis from the 13 (S)-hydroperoxide of linolenic acid | |
| EA200100589A1 (ru) | Азабициклоалканы как модуляторы ccr5 | |
| NO20013971D0 (no) | Fremgangsmate ved fremstilling av (2R)-2-propyloktansyre | |
| IE57200B1 (en) | Dopamine-beta-hydroxylase inhibitors | |
| Boeynaems et al. | Transformation of arachidonic acid into an iodolactone by the rat thyroid. | |
| AU4773790A (en) | Preparation of basic aluminium halides | |
| NO20071498L (no) | Substituerte acylhydroksamsyrer samt fremgangsmate for a redusere TNFa-nivaet | |
| BR0016665A (pt) | Composição alvejante, e, métodos de alvejamento e de preparação de uma composição alvejante | |
| NO962490L (no) | Orale formuleringer av S(+)-ibuprofen | |
| Crouch et al. | Interaction of calmodulin with skeletal muscle myosin light chain kinase | |
| Majeski et al. | Controlled potential oxidation of anthracene in acetonitrile. II | |
| TR200100109T2 (tr) | Optikçe aktif oktanoik asit türevleri hazırlamak için yeni ara bileşikler ve yöntemler | |
| AU582235B2 (en) | Quinolylglycinamide derivatives,the process for preparation thereof and their therapeutic application as psychotropic drugs | |
| NO993533D0 (no) | Fremgangsmåte for stabilisering av peptider, samt frysetoerkede medisinske preparater som inneholder peptider erholdt ved å anvende fremgangsmåten | |
| FI854926A0 (fi) | Foerfarande foer framstaellning av farmakologiskt aktiva pyrrolobensimidazoler. | |
| Sourkes et al. | Reduction of methionine sulfoxides by Escherichia coli | |
| DE69133077D1 (de) | Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung | |
| ES2030432T3 (es) | Preparacion de haluros de aluminio basicos. | |
| Wegmann et al. | Selective ion monitoring of tryptophan, N-acetyltryptophan and kynurenine in human serum: Applicatin to the in vivo measurement of tryptophan pyrrolase activity | |
| AU581185B2 (en) | Process for the racemization of optically active aminoacids | |
| Jackson et al. | Effect of heat on some collagen cross-links | |
| Gershon et al. | Amino acid analogs. 2. 3-Fluoroamino acids. 1. Chain length three to seven carbon atoms | |
| AU6565886A (en) | Oligomericdiazaoxaspirodecanes, preparation thereof and use thereof as light stabilizers for polymers | |
| Wildberger et al. | Regulation of enzymatic iodothyronine synthesis in thyroglobulin by low concentrations of iodide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |